CASI Pharmaceuticals
CASI
#10569
Rank
HK$33.41 M
Marketcap
HK$1.63
Share price
0.00%
Change (1 day)
-90.09%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): -HK$21.61

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$21.71. In 2024 the company made an earnings per share (EPS) of -HK$20.06 a decrease over its 2023 EPS that were of -HK$15.83.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$21.617.72%
2024-HK$20.0626.73%
2023-HK$15.83-32.89%
2022-HK$23.5911.9%
2021-HK$21.08-38.44%
2020-HK$34.24-8.96%
2019-HK$37.6150%
2018-HK$25.0877.78%
2017-HK$14.115.88%
2016-HK$13.32-22.73%
2015-HK$17.24-76.09%
2014-HK$72.09318.18%
2013-HK$17.24-71.79%
2012-HK$61.1265.96%
2011-HK$36.83-50%
2010-HK$73.66-18.97%
2009-HK$90.90-63.64%
2008-HK$249.973.57%
2007-HK$241.35-60.56%
2006-HK$612.0097.22%
2005-HK$310.31-2.7%
2004-HK$318.93-45.59%
2003-HK$586.14-61.8%
2002-HK$1,534-25.52%
2001-HK$2,060-21.38%
2000-HK$2,62013.86%
1999-HK$2,301149.53%
1998-HK$922.3198.15%
1997-HK$465.4710.2%
1996-HK$422.37